SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis.

Abstract:

:Epithelial-mesenchymal transition (EMT) is a process during which normal epithelial cells acquire mesenchymal characteristics. EMT has a critical role in various human diseases especially in cancer. EMT facilitates tumor initiation and progression by mediating cancer cell stemness and motility. Zinc finger transcription factor SNAIL is one of the most important initiators of EMT. Therefore, it is of great significance to understand the regulating mechanism of SNAIL. In this study, we carried out a luciferase-based genome-wide screening using small interfering RNA library against ~200 of E3 ligases and ubiquitin-related genes and identified SOCS box protein SPSB3 as a novel E3 ligase component that targets SNAIL into polyubiquitination and degradation in response to GSK-3β phosphorylation of SNAIL. Functionally, we observed that SPSB3 overexpression greatly inhibits tumor metastasis by regulating SNAIL degradation both in vitro and in vivo. The expression of SPSB3 and SNAIL are negatively correlated in human esophageal squamous cell carcinoma tissues, and low SPSB3 expression indicates lymph node metastasis. Moreover, high SPSB3 expression indicates good survivals in various kinds of cancer. Collectively, these findings suggest that SPSB3-mediated SNAIL degradation has a vital role in regulating EMT and cancer progression.

journal_name

Oncogene

journal_title

Oncogene

authors

Liu Y,Zhou H,Zhu R,Ding F,Li Y,Cao X,Liu Z

doi

10.1038/onc.2017.370

subject

Has Abstract

pub_date

2018-02-08 00:00:00

pages

768-776

issue

6

eissn

0950-9232

issn

1476-5594

pii

onc2017370

journal_volume

37

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Targeting the RB-E2F pathway in breast cancer.

    abstract::Mutations of the retinoblastoma tumor-suppressor gene (RB1) or components regulating the CDK-RB-E2F pathway have been identified in nearly every human malignancy. Re-establishing cell cycle control through cyclin-dependent kinase (CDK) inhibition has therefore emerged as an attractive option in the development of targ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.32

    authors: Johnson J,Thijssen B,McDermott U,Garnett M,Wessels LF,Bernards R

    更新日期:2016-09-15 00:00:00

  • Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis.

    abstract::The p53 tumor suppressor protein and the Akt/PKB kinase play important roles in the transduction of pro-apoptotic and anti-apoptotic signals, respectively. We provide evidence that conflicting signals transduced by Akt and p53 are integrated via negative feedback between the two pathways. On the one hand, the combinat...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205181

    authors: Gottlieb TM,Leal JF,Seger R,Taya Y,Oren M

    更新日期:2002-02-14 00:00:00

  • Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression.

    abstract::Previous observations suggest expression of cyclooxygenase-2 to convey macrophage protection towards apoptotic cell death. We reasoned prostaglandin formation and in turn a cAMP increase as the underlying protective principle. Here we report that exposure of macrophages to lipopolysaccharide/interferon-gamma or lipoph...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201926

    authors: von Knethen A,Lotero A,Brüne B

    更新日期:1998-07-23 00:00:00

  • Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.

    abstract::In the course of screening for inhibitors of tumorigenic phenotype of K-ras-transformed NIH3T3 cells (DT cells), we found a novel compound, oxamflatin, an aromatic sulfonamide hydroxamate derivative, which induces flat phenotype in these cells and suppresses their anchorage-independent growth. In contrast to DT cells,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sonoda H,Nishida K,Yoshioka T,Ohtani M,Sugita K

    更新日期:1996-07-04 00:00:00

  • Cellular ITAM-containing proteins are oncoproteins in nonhematopoietic cells.

    abstract::Immunoreceptor tyrosine-based activation motifs (ITAMs) are involved in the transduction of signals necessary for activation, differentiation, and survival in hematopoietic cells. Several viruses have been shown to encode ITAM-containing transmembrane proteins. Although expression of these viral proteins has in some c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209296

    authors: Grande SM,Katz E,Crowley JE,Bernardini MS,Ross SR,Monroe JG

    更新日期:2006-05-04 00:00:00

  • Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway.

    abstract::Non-small cell lung carcinomas (NSCLCs) are typically resistant against apoptosis induced by standard chemotherapy. We evaluated the effects of the two potential antitumor agents of the lamellarin class on a highly apoptosis-resistant NSCLC cell line. Both the marine alkaloid lamellarin-D and its synthetic amino deriv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210833

    authors: Gallego MA,Ballot C,Kluza J,Hajji N,Martoriati A,Castéra L,Cuevas C,Formstecher P,Joseph B,Kroemer G,Bailly C,Marchetti P

    更新日期:2008-03-27 00:00:00

  • Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.

    abstract::A flow cytometric assay was developed to examine the expression of the cellular myc oncogene in relation to cell cycle in individual cells. C-myc-oncoprotein was detected by indirect immunofluorescence using a purified sheep polyclonal antibody, anti-human-myc. Specific binding of anti-human-myc was measured by flow c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mohamed AN,Nakeff A,Mohammad RM,KuKuruga M,al-Katib A

    更新日期:1988-10-01 00:00:00

  • Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.

    abstract::Upregulation of acidic and basic fibroblast growth factors (FGF-1 and -2), and their cognate receptors FGFR-1 and -2, has been demonstrated in a variety of epithelial malignancies. However, the patterns of FGF/FGFR expression at specific stages of epithelial carcinogenesis have not been extensively characterized. In t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Arbeit JM,Olson DC,Hanahan D

    更新日期:1996-11-07 00:00:00

  • The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor alpha promoter.

    abstract::Transcription from the rat transforming growth factor alpha (TGF-alpha) promoter initiates at multiple sites within a 200-bp G+C-rich region that lacks TATA and CAAT motifs but contains multiple potential binding sites for the transcription factor Sp1. In the present study, we used deletion analysis to establish the 5...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chen X,Azizkhan JC,Lee DC

    更新日期:1992-09-01 00:00:00

  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

    abstract::Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0872-9

    authors: Yuan X,Larsson C,Xu D

    更新日期:2019-08-01 00:00:00

  • Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.

    abstract::Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with increased incidence of metastases. We and others demonstrated that nuclear ErbB-2 (NErbB-2) also plays a key role in BC and is a poor prognostic factor in ErbB...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.281

    authors: Venturutti L,Romero LV,Urtreger AJ,Chervo MF,Cordo Russo RI,Mercogliano MF,Inurrigarro G,Pereyra MG,Proietti CJ,Izzo F,Díaz Flaqué MC,Sundblad V,Roa JC,Guzmán P,Bal de Kier Joffé ED,Charreau EH,Schillaci R,Elizalde PV

    更新日期:2016-04-28 00:00:00

  • Transformation of NIH3T3 cells by A-MuLV proviral DNA: effect of plasmid linearization and carrier DNA on transformation efficiency.

    abstract::We have optimized the conditions for efficient NIH3T3 focus formation by calcium phosphate transfection of proviral Abelson-murine leukemia virus (A-MuLV) plasmid DNA. Linearized pA-MuLV, P120 or P160 strains, when transfected with calf thymus carrier DNA, will produce 40-50 foci/100 ng pA-MuLV without co-transfecting...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shore SK,Reddy EP

    更新日期:1989-11-01 00:00:00

  • Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium.

    abstract::The transcription factor NF-kappa-B is normally sequestered in the cytoplasm by its inhibitory subunit IkappaB. Most extracellular signals activate NF-kappa-B through a mechanism involving the phosphorylation and proteasome-dependent degradation of IkappaB. EGF activates NF-kappaB in A-431 carcinoma cells, which overe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201731

    authors: Sun L,Carpenter G

    更新日期:1998-04-23 00:00:00

  • TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    abstract::Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine with the capability to act as tumour suppressor or tumour promoter depending on the cellular context. TGF-beta receptor type-2 (TGFBR2) is the ligand-binding receptor for all members of the TGF-β family. Data from mouse model experiments demonstrated th...

    journal_title:Oncogene

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/onc.2013.527

    authors: Busch S,Acar A,Magnusson Y,Gregersson P,Rydén L,Landberg G

    更新日期:2015-01-02 00:00:00

  • Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.

    abstract::Arg and c-Abl represent the mammalian member of the Abelson family of nonreceptor protein tyrosine kinases. The two proteins are composed of SH2, SH3, kinase and C-terminal domains. To examine Arg structure-function relationships we analysed a Gag-Arg fusion protein, analogous to the oncogenic Gag-Abl fusion protein o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mysliwiec T,Perego R,Kruh GD

    更新日期:1996-02-01 00:00:00

  • Concentration-dependent positive and negative regulation of a MAP kinase by a MAP kinase kinase.

    abstract::There are at least three distinct MAP kinase signaling modules in mammalian cells, distinguished by the family of kinases (Erk, SAPK/JNK, or p38) that is ultimately activated. Many input signals activate multiple MAP kinase cascades, and the mechanisms that control the specificity of signal output are not well underst...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203057

    authors: Kieran MW,Katz S,Vail B,Zon LI,Mayer BJ

    更新日期:1999-11-18 00:00:00

  • Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing.

    abstract::Homology PCR has been used to identify receptor tyrosine kinases (RTKs) expressed during activation of rat hepatic stellate cells, the key fibrogenic mesenchymal element in the liver. Partial cDNAs encoding several RTKs were cloned from stellate cells activated in vivo, including those of Flt-1, Flk-1, c-met, PDGFR, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201912

    authors: Ankoma-Sey V,Matli M,Chang KB,Lalazar A,Donner DB,Wong L,Warren RS,Friedman SL

    更新日期:1998-07-09 00:00:00

  • Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

    abstract::Silencing of gene expression by methylation of CpG islands in regulatory elements is frequently observed in cancer. However, an influence of the most common oncogenic signalling pathways onto DNA methylation has not yet been investigated thoroughly. To address this issue, we identified genes suppressed in HRAS-transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209502

    authors: Lund P,Weisshaupt K,Mikeska T,Jammas D,Chen X,Kuban RJ,Ungethüm U,Krapfenbauer U,Herzel HP,Schäfer R,Walter J,Sers C

    更新日期:2006-08-10 00:00:00

  • Essential roles of Crk and CrkL in fibroblast structure and motility.

    abstract::Cytosolic proteins containing SH2 and SH3 domains, such as Crk and Crk-like (CrkL), are broadly expressed adapters that interact with a variety of proteins to fulfill key roles in signal transduction pathways triggered by activation of receptor and non-receptor tyrosine kinases. Crk and CrkL are similar to each other ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.453

    authors: Park TJ,Curran T

    更新日期:2014-10-23 00:00:00

  • p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis.

    abstract::p8 is a stress-induced DNA-binding protein, biochemically related to the architectural chromatin binding HMG protein family and whose function is presently unknown. We obtained fibroblast from mice lacking p8 and found that p8 is involved in cell growth regulation and in apoptosis. p8(-/-) mouse embryonic fibroblasts ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205222

    authors: Vasseur S,Hoffmeister A,Garcia-Montero A,Mallo GV,Feil R,Kühbandner S,Dagorn JC,Iovanna JL

    更新日期:2002-03-07 00:00:00

  • DNA binding and selective gene induction by different forms of the p53 protein.

    abstract::P53 is a tumor suppressor gene that plays a crucial role in suppressing tumorigenesis by inducing either cell cycle arrest or apoptosis in cells with DNA damage. In more than 50% of tumors p53 is inactivated by gene mutations. However, there have also been reports of tumor cells in which p53 remains wild type and is p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210110

    authors: Mayelzadeh F,Martinez JD

    更新日期:2007-05-10 00:00:00

  • Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) are devastating sarcomas for which no effective medical therapies are available. Over 50% of MPSNTs are associated with mutations in NF1 tumor suppressor gene, resulting in activation of Ras and its effectors, including the Raf/Mek/Erk and PI3K/Akt/mTORC1 signaling cas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.143

    authors: Semenova G,Stepanova DS,Dubyk C,Handorf E,Deyev SM,Lazar AJ,Chernoff J

    更新日期:2017-09-21 00:00:00

  • Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.

    abstract::Polymerase chain reaction (PCR) analysis of microsatellite polymorphisms corresponding to four loci which map to chromosome 17p and 11 loci which map to chromosome 17q was performed to screen for loss of heterozygosity (LOH) in paired normal and tumor tissues from 27 cases of borderline epithelial ovarian tumors (BEOT...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wertheim I,Tangir J,Muto MG,Welch WR,Berkowitz RS,Chen WY,Mok SC

    更新日期:1996-05-16 00:00:00

  • Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.

    abstract::The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) has a significant role in initiating EBV-associated lymphoproliferative disease and EBV-related malignancies. In view of clinical features related to the type of EBV latency, LMP1 may influence invasiveness of EBV associated tumors categorized as ty...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203502

    authors: Kim KR,Yoshizaki T,Miyamori H,Hasegawa K,Horikawa T,Furukawa M,Harada S,Seiki M,Sato H

    更新日期:2000-03-30 00:00:00

  • Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.

    abstract::The REL gene is amplified in many human B-cell lymphomas and we have previously shown that expression of REL from a retroviral vector can malignantly transform chicken spleen cells in vitro. To identify REL protein functions necessary for malignant transformation, we have performed deletion analysis on REL sequences e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206801

    authors: Starczynowski DT,Reynolds JG,Gilmore TD

    更新日期:2003-10-09 00:00:00

  • rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral.

    abstract::A novel oncogene, rsc (rabbit squamous cell carcinoma), has been identified from a DMBA-induced rabbit squamous cell carcinoma using gene transfer and the nude mouse tumorigenesis assay. A full-length cDNA has been isolated and sequenced. rsc has potent tumorigenic activity in nude mice (latency <4 weeks), but does no...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200950

    authors: D'Adamo DR,Novick S,Kahn JM,Leonardi P,Pellicer A

    更新日期:1997-03-20 00:00:00

  • Epigenetic regulations in hematopoietic Hox code.

    abstract::Hox genes encode DNA-binding proteins that are deployed in overlapping domains along various body axes during embryonic development. This sequential activation of Hox genes in temporal and spatial mode, the Hox code, is critical for the proper positioning of segmented structures along those axes, which include the ver...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.484

    authors: He H,Hua X,Yan J

    更新日期:2011-01-27 00:00:00

  • Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.

    abstract::We have previously demonstrated the existence of a melanoma tumor suppressor gene(s) on the long arm of chromosome 11 through suppression of tumorigenicity assays. Although loss of heterozygosity studies also support this finding, only a large critical region (44 cM) has been identified to date on 11q22-25. To further...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202664

    authors: Robertson GP,Goldberg EK,Lugo TG,Fountain JW

    更新日期:1999-05-20 00:00:00

  • HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma.

    abstract::Hepatocyte nuclear factor 4alpha (HNF4alpha) is a tissue-specific transcription factor known to regulate a large number of genes in hepatocytes and pancreatic beta cells. Although HNF4alpha is highly expressed in some sections of the kidney, little is known about its role in this organ and about HNF4alpha-regulated ge...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208794

    authors: Lucas B,Grigo K,Erdmann S,Lausen J,Klein-Hitpass L,Ryffel GU

    更新日期:2005-09-22 00:00:00

  • Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.

    abstract::Smad4 is a critical component in transforming growth factor beta (TGF-beta) signaling and frequently mutated in pancreatic and colorectal cancers. Smad4 has two important functional domains, MH1 and MH2, that are involved in different biological processes. The MH1 domain comprises a DNA binding domain and the MH2 doma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207219

    authors: Kuang C,Chen Y

    更新日期:2004-02-05 00:00:00